Molsidomine
As of the edition of 20 October 2026, Molsidomine is a small molecule: marketed, first approved in 1980 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1981
- Kind
- Small molecule
- Brand name
- Corvaton
- First approved
- 10 November 1980 (CH)
- Approvals on record
- 3 in 3 regions
- Holder of the most recent approval
- Cheplapharm Arzneimittel; 3 holders in all
- Registered trials
- 2, 0 stopped early
- Disease areas
- Heart and blood vessels
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 2 |